HQL
abrdn Life Sciences Investors
HQL
HQL
49 hedge funds and large institutions have $57.5M invested in abrdn Life Sciences Investors in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $73.9M → $57.5M (-$16.4M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
49
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.33M | |
| 3 | +$689K | |
| 4 |
DA
Doliver Advisors
Houston,
Texas
|
+$590K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$587K |
Top Sellers
| 1 | -$8.25M | |
| 2 | -$4.36M | |
| 3 | -$3.27M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.25M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.95M |